Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 776.00M | 864.40M | 770.40M | 762.10M | 717.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 776.00M | 864.40M | 770.40M | 762.10M | 717.40M |
| Cost of Revenue | 614.10M | 630.80M | 592.90M | 582.90M | 562.10M |
| Gross Profit | 161.90M | 233.60M | 177.50M | 179.20M | 155.30M |
| SG&A Expenses | 36.00M | 36.00M | 29.20M | 40.30M | 33.20M |
| Depreciation & Amortization | 36.30M | 33.90M | 50.20M | 34.80M | 33.70M |
| Other Operating Expenses | -- | -9.30M | -2.20M | -6.50M | -2.00M |
| Total Operating Expenses | 686.40M | 691.40M | 670.10M | 651.50M | 627.00M |
| Operating Income | 89.60M | 173.00M | 100.30M | 110.60M | 90.40M |
| Income Before Tax | -300.00K | 74.20M | 10.90M | 33.30M | 28.70M |
| Income Tax Expenses | -- | 120.80M | 4.50M | 4.90M | 4.40M |
| Earnings from Continuing Operations | -300.00K | -46.60M | 6.40M | 28.40M | 24.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -37.40M | -61.90M | -38.10M | -43.90M | -36.70M |
| Net Income | -37.70M | -108.50M | -31.70M | -15.50M | -12.40M |
| EBIT | 89.60M | 173.00M | 100.30M | 110.60M | 90.40M |
| EBITDA | 125.90M | 206.90M | 150.50M | 145.40M | 124.10M |
| EPS Basic | -0.30 | -0.86 | -0.25 | -0.12 | -0.10 |
| Normalized Basic EPS | -0.13 | 0.14 | -0.03 | -0.03 | -0.06 |
| EPS Diluted | -0.30 | -0.86 | -0.25 | -0.12 | -0.10 |
| Normalized Diluted EPS | -0.13 | 0.14 | -0.03 | -0.03 | -0.06 |
| Average Basic Shares Outstanding | 126.60M | 126.21M | 126.17M | 126.13M | 125.97M |
| Average Diluted Shares Outstanding | 126.60M | 126.21M | 126.17M | 126.13M | 125.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |